SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,264.51 330.92
( 0.43%)

Global Indices

Nasdaq

53,569.16 -21.28
(-0.04%)

Dow Jones

7,731.77 -20.22
(-0.26%)

Hang Seng

66,369.62 237.64
(0.36%)

Nikkei 225

10,816.31 23.77
(0.22%)

Forex

USD-INR

95.26 -0.05
(-0.05%)

EUR-INR

111.07 -0.11
(-0.10%)

GBP-INR

129.70 -0.28
(-0.21%)

JPY-INR

0.60 0.00
(0.01%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Anthem Biosciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

544449

INE0CZ201020

56.5500337

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ANTHEM

50723.44

EPS(TTM)

Face Value()

Div & Yield %

11.4

0.22

Back

Samvardhana Motherson International consolidated net profit rises 101.64% in the June 2026 quarter

Aug 06,2026

Net profit of Samvardhana Motherson International rose 101.64% to Rs 1032.05 crore in the quarter ended June 2026 as against Rs 511.84 crore during the previous quarter ended June 2025. Sales rose 16.60% to Rs 34912.40 crore in the quarter ended June 2026 as against Rs 29942.83 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	34912.40	29942.83	17
OPM %	8.87	8.21	-
PBDT	2891.10	2238.05	29
PBT	1532.89	1008.33	52
NP	1032.05	511.84	102

77,264.51 330.92 ( 0.43%)

53,569.16 -21.28 (-0.04%)

7,731.77 -20.22 (-0.26%)

66,369.62 237.64 (0.36%)

10,816.31 23.77 (0.22%)

95.26 -0.05 (-0.05%)

111.07 -0.11 (-0.10%)

129.70 -0.28 (-0.21%)

0.60 0.00 (0.01%)